Oct 03, 2025

MP Biomedicals Launches MagFlex-96: A High-Throughput, Flexible Platform for Automated Nucleic Acid Purification

3rd October 2025 — MP Biomedicals is pleased to announce the launch of the MagFlex-96 automated Nucleic Acid Purification (aNAP) System, a next-generation instrument designed to deliver high-throughput, flexible, and reliable magnetic bead–based extraction for laboratories of all scales. The

Jan 11, 2024

Nucleic acid extraction microbes

Jun 25, 2024

MP Biomedicals Announces the Launch of Advanced Gastrointestinal Diseases Diagnostic Kits

Eschwege, Germany - June 27, 2024 – MP Biomedicals, a global leader in life sciences and diagnostic solutions, is proud to announce the launch of its innovative range of gastrointestinal diseases diagnostic kits. These state-of-the-art diagnostic solutions are designed to provide rapid, accurate, and reliable detection of a wide range of gastrointestinal conditions, enhancing patient care and advancing clinical research.

Jan 23, 2024

Introducing MagBeads FastDNA™ and FastRNA™ Extraction Kits

MP Biomedicals has launched MagBeads FastDNA™ and FastRNA™ Kits. which offer scalability for seamless transitions from proof-of-concept to larger studies, supporting both manual and automated workflows. Utilizing magnetic bead-based technology, these kits ensure efficient extraction of DNA/RNA with high purity, yield, and integrity, ready for immediate use in downstream applications.

Nov 02, 2023

Introducing SPINeasy Nucleic Acid Extraction and Purification Kits 

MP Biomedicals has launched SPINeasy Nucleic Acid Extraction Kits, offering highly pure DNA and RNA for molecular biology applications. The kits are fast, efficient, and suitable for various sample types, demonstrating MP Bio's commitment to quality.

Aug 22, 2023

MP Biomedicals receives "Emerging Brand of the Year" award.

Exciting News! MP Biomedicals has been honoured with the prestigious "Emerging Brand of the Year" award at the Vaccine Leader Conclave on 22nd of August 2023 in Mumbai, a momentous event attended by industry luminaries, and organized by Bluetech Media.

Jul 20, 2023

How We Prevented an Inevitable Disruption to Manufacturing and Helped Ensure the Gift of Tissue Donation Using a Combination of our Catalog Products and Custom Manufacturing Capabilities

The customer, a tissue processor, a company that manufactures tissue grafts and biologics from donated human musculoskeletal tissues, was utilizing a gentamicin sulfate solution, an antibiotic that inhibits the growth of a wide variety of Gram-positive and Gram-negative microorganisms, as part of their aseptic manufacturing process.

Mar 21, 2023

MP Biomedicals, LLC to offer a comprehensive selection of specialty reagents and consumables for protein assays and Western Blotting

• High-quality protein extraction buffers, loading buffers, and protein ladders for accurate molecular weight measurements
• Time savings during electrophoresis with cost-effective pre-cast gels and fast staining solutions
• Enhanced signal detection and better band visualization with Western Blot specialty reagents

Jan 24, 2023

MP Biomedicals launches in EMEA rapid tests for respiratory infectious diseases

Our rapid tests for COVID antigens detection as well as IgG and IgM antibodies assessment have already proved their worth on the European market and abroad. MP Biomedicals will continue to serve its mission of advancing the world of health. Accordingly, MP Biomedicals focused on developing immunochromatographic assays for respiratory infectious disease detection. In this line, we are happy to launch a group of three IVD rapid tests dedicated for the in vitro qualitative detection of 2019-nCoV, influenza type A, and influenza type B antigens. These tests are CE-marked and for professional use only.

Sep 29, 2022

MP Biomedicals launches new antibodies, antigens, and ELISA kits to advance SARS-CoV-2 research

MP Biomedicals, LLC has recently expanded its portfolio of COVID-19 related research products to include a wide selection of highly pure SARS-CoV-2 recombinant proteins, monoclonal antibodies specific and potent against a variety of SARS-CoV-2 protein domains, and high-quality ELISA kits to quantify SARS-CoV-2 and the virus-triggered human IgM and IgG antibodies.